OKRA.ai

"The journey toward a fully realized AI-driven future in pharma may be complex, but the rewards for those who successfully navigate this path will be transformative." – Jim Streeter, President of Technology, Chief Technology Officer. As the pharmaceutical industry evolves, embracing AI is becoming essential for medical affairs professionals. In our latest guidebook, "AI adoption guidebook for medical affairs," Jim Streeter and Yahya Anvar, Head of OKRA.ai, provide insights on how AI can enhance data analytics, streamline content creation, and ultimately improve patient outcomes. Explore practical strategies to assess your organization's readiness for AI and pinpoint key areas where it can deliver immediate impact and value. Download the guidebook now! 👇 https://lnkd.in/eT68vwUN #AIinPharma #MedicalAffairs #HealthcareInnovation

Medical Brain by OKRA.ai, an Envision Pharma Group company, leverages AI to help medical teams create a fully automated insights generation process that enables them to reach both local and global insights – all in a single platform. What makes the Medical Brain a game-changer? It empowers medical teams to uncover trends, monitor sentiment, pinpoint evidence gaps, and tackle unmet needs effortlessly – reducing time to insights by 80%. Explore our latest case study to see the Medical Brain in action 👉 https://lnkd.in/eci9R6an

We’re proud to share that Envision Pharma Group’s OKRA.ai is named as a Sample Vendor in the Gartner® Hype Cycle™ for Life Science Commercial Operations, 2024 report. A key focus of the report is scaling the use of data and analytics to accelerate decision-making processes and improve strategic outcomes – a guiding principle we share at Envision. Our proprietary AI technology, Medical Brain, transforms data into actionable medical insights highlighting significant trends, sentiments, evidence gaps, and unmet needs – all within a single, unified solution, proven to reduce time to action by up to 80%. Ready to learn more? Access the full reprint from Gartner® including commentary, analysis, and what’s new here: https://lnkd.in/eKEYkXh4. #MedicalAffairs #MedicalData #HealthcareInnovation

🎉 We’re thrilled to see OKRA.ai named as one of the “7 Pioneering Companies Leading AI and Data-Driven European Healthcare in 2024”! 💚   As Yahya Anvar, GM and Head of OKRA.ai, says, “Our mission is to use AI not just for innovation, but to truly empower people in making decisions that enhance healthcare delivery.”    🚀 This recognition celebrates our progress at OKRA.ai and Envision Pharma Group to empower healthcare professionals and organizations with innovative tools to drive impactful change. 🙌   Many thanks for the recognition Panda Intelligence ✨

In a data-rich world, the Medical Brain by OKRA.ai, an Envision Pharma Group company, leverages AI to help medical teams cut through the noise and uncover actionable insights from diverse sources, such as medical science liaison notes, clinical trials, publications, and more – all within a single platform. 🎯 What can the Medical Brain do? It empowers teams to identify trends, track sentiment, detect evidence gaps, and address unmet needs efficiently, all with zero manual effort. Curious about how the Medical Brain could transform your insights journey? Check our case study 👉 https://lnkd.in/eci9R6an

🚀 Through the tremendous efforts of our dedicated OKRA.ai team, we uncovered actionable and impactful insights for our recent client.💚 🧠 Analysing over 100.000 data records from 50 countries in just 2 weeks! ✨ Check out our new OKRA.ai case study 👇 https://lnkd.in/eci9R6an

✨ Our team is waiting for you at the Cambridge Engineering & Tech Careers Fair today 💚 Come find us and let’s discuss the incredible opportunities ahead! 🤝 Careers Service, University of Cambridge #Engineering #TechFair #AIInnovation #FutureLeaders #OKRA

Join us for an exciting panel session titled “Generative AI: The hype is over” at the 2024 #Pharmageddon Europe conference in Amsterdam. This forum will reassess generative AI and explore how to harness its true potential in medical affairs to drive performance. Paul Simms will moderate the panel, featuring Yahya Anvar – OKRA.ai, Mirkka Schaller, PhD – Alexion, Karsten Friedrich – AstraZeneca, and Dr. Myles Furnace – Impatient Health. Dr. Yahya Anvar, General Manager and Head of #OKRA, will share his valuable insights on the data overload in the pharma industry and how medical teams can successfully deploy AI. #MedicalAffairs #AI #ArtificialIntelligence 

We're thrilled to announce our participation in the 2024 #Pharmageddon Europe conference in Amsterdam! Envision and OKRA.ai will be there to engage with the pharma community and patients. Our focus at the event extends beyond traditional offerings. We aim to make a lasting impact through providing smarter, faster outcomes as a leading technology-enabled solutions provider. Connect with Yahya Anvar, Paul Archer, Andrew Thompson, and Özge Özgüleryüz to discuss reshaping the life sciences industry with the help of AI during Impatient Health's Pharmageddon. #MedicalAffairs #AI #ArtificialIntelligence 

Discover how our AI platform, OKRA.ai, has been used to empower continuous insights by evolving from manual reports to automated AI solutions for actionable data. Our case study showcases the value #OKRA delivers to our clients, including: 🚀 80% reduction in time to insight ⏰ Time to client action: 1 month versus 5 months ⚙️ 100% automation 🔄 Closed feedback loop 🎯 AI deployment in just 4 weeks Download the case study 👉 https://lnkd.in/dn2n7fyR